Evaluation of the Effects of Laughter Yoga
Recruiting · NCT07524231 · Interventional (participants receive a specific treatment) · Lead sponsor: Firat University
View the official record on ClinicalTrials.gov →Interventions studied
Laughter Yoga
What this trial is about
This randomized controlled study aims to evaluate the effects of laughter yoga on pain intensity, fatigue, and beta-endorphin levels in patients with Multiple Sclerosis. Laughter yoga, a complementary therapy combining breathing exercises and laughter techniques, may help improve symptom management and psychological well-being in individuals with MS.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- • Being over 18 years old
- Being able to communicate adequately
- Volunteering to participate in the research
Exclusion criteria
- Unwillingness to participate in the study
- Having severe cognitive impairment that prevents understanding or participation in the intervention
- Having a psychiatric disorder that may affect participation in the study
- Experiencing an acute MS relapse during the study period
- Having another serious neurological or chronic disease that may affect the study outcomes
- Regular participation in another complementary therapy program similar to laughter yoga
- Communication problems that prevent participation in the intervention sessions
Where it is running
1 location listed.
- Gül DURAL - Elâzığ, Turkey (Türkiye)